2014
DOI: 10.1016/j.jorganchem.2013.10.057
|View full text |Cite
|
Sign up to set email alerts
|

2,3-Dihydroimidazo[1,2-b]ferroceno[d]pyridazines and a 3,4-dihydro-2H-pyrimido[1,2-b]ferroceno[d]pyridazine: Synthesis, structure and in vitro antiproliferation activity on selected human cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 69 publications
0
10
0
Order By: Relevance
“…Prompted by the aforementioned highly promising precedents, in the frame of our ongoing research aimed at identification of novel leads including ferrocene hybrids [22][23][24][25][26][27][28][29] we envisaged atryptamine-and tryptophan-based synthesis, detailed structural analysis and preliminary in vitro evaluation of 6-aryl-substituted 5,6,8,9,14,14b-hexahydroindolo [2 ,3 :3,4]pyrido [1,2-c]quinazolines (I), 5,5b,17,18-tetrahydroindolo [2 ,3 :3,4]pyrido [1,2-c]isoindolo[2,1-a]quinazolin-11(15bH)-ones (II), and (S p )-2-formyl-1-ferrocenecarboxylate-derived 5,5b, 11,14b,16,17-hexahydroindolo [2 ,3 :3,4]pyrido [1,2-c]ferroceno[c]pyrrolo[1,2-a]quinazoline-11(14bH)-ones (III), featuring alkaloid-like frameworks with diverse stereostructures (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Prompted by the aforementioned highly promising precedents, in the frame of our ongoing research aimed at identification of novel leads including ferrocene hybrids [22][23][24][25][26][27][28][29] we envisaged atryptamine-and tryptophan-based synthesis, detailed structural analysis and preliminary in vitro evaluation of 6-aryl-substituted 5,6,8,9,14,14b-hexahydroindolo [2 ,3 :3,4]pyrido [1,2-c]quinazolines (I), 5,5b,17,18-tetrahydroindolo [2 ,3 :3,4]pyrido [1,2-c]isoindolo[2,1-a]quinazolin-11(15bH)-ones (II), and (S p )-2-formyl-1-ferrocenecarboxylate-derived 5,5b, 11,14b,16,17-hexahydroindolo [2 ,3 :3,4]pyrido [1,2-c]ferroceno[c]pyrrolo[1,2-a]quinazoline-11(14bH)-ones (III), featuring alkaloid-like frameworks with diverse stereostructures (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
“…Prompted by the aforementioned highly promising precedents, in the frame of our ongoing research aimed at identification of novel leads including ferrocene hybrids [22][23][24][25][26][27][28][29] we envisaged atryptamine-and tryptophan-based synthesis, detailed structural analysis and preliminary in vitro evaluation of 6-aryl-substituted 5,6,8,9,14,14b-hexahydroindolo[2',3':3,4]pyrido [1,2-c]quinazolines (I), 5,5b,17,18-tetrahydroindolo [2',3':3,4]pyrido [1,2-c]isoindolo[2,1-a]quinazolin-11(15bH)-ones (II), and (Sp)-2-formyl-1-ferrocenecarboxylate-derived 5,5b, 11,14b,16,17- A straightforward retrosynthetic analysis of pentacycles type I set up an obvious synthetic pathway starting with a Pictet-Spengler (PS) annelation involving tryptophan-based precursors and Molecules 2020, 25, 1599 3 of 25 2-nitrobenzaldehyde followed by nitro group reduction and subsequent aldehyde-mediated cyclisation of the resulting 2-aminophenyl-substituted β-carboline framework to construct the targeted pentacyclic products (Scheme 1). Accordingly, tryptamine (1) was first converted into the nitrophenyl derivative 3 by an efficient PS protocol using an acetic acid/boric acid system at reflux temperature to promote the reaction [30] which practically went to completion within 4 h and allowed the isolation of the product as a racemic mixture in 85% yield.…”
Section: Resultsmentioning
confidence: 99%
“…Unfortunately, the use of transition metal in chemotherapy is often accompanied with severe side effects [30]. Aiming to overcome the toxic limitations and to broaden the scope of treatable malignancies, research lead to the discovery of one of the fused ferrocene derivatives, (Sp)-ferroceno[d]pyridazine [31] (cpd 2), it's in vitro antitumour activity was investigated against HepG2 hepatoma and HT-29 colorectal adenocarcinoma cell cultures by (MTT) assay.…”
Section: Dna Chelatorsmentioning
confidence: 99%
“…The effect of stereochemistry on biological activity is of great importance in medicinal chemistry, as many of the biological targets are chiral [30,31]. The anticancer properties of chiral metal derivatives have been largely studied [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46], but the role of the stereochemistry in the biological activity of non-platinum based compounds has been less investigated [22,[47][48][49][50][51][52][53][54][55][56][57][58][59][60][61]. Effect of the absolute configuration on the anticancer efficiency of titanium compounds was firstly explored by Tshuva in 2010 [50].…”
Section: Introductionmentioning
confidence: 99%